Advanced Biomed (ADVB) Accumulated Expenses (2024 - 2026)

Advanced Biomed has reported Accumulated Expenses for 3 years, with the latest figure at $238538.0 in Q1 2026.

• Quarterly Accumulated Expenses rose 119.75% year-over-year to $238538.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $238538.0 (up 119.75% YoY) and the FY2025 annual result came in at $575831.0, up 646.74% from the prior year.
• Accumulated Expenses grew to $238538.0 in Q1 2026 per ADVB's latest filing, from $224038.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $1.2 million in Q4 2024 and troughed at $73333.0 in Q3 2025.
• A 3-year average of $358121.3 and a median of $224038.0 in 2025 frame the typical range for Accumulated Expenses.
• The widest YoY moves for Accumulated Expenses: up 646.74% in 2025, down 81.48% in 2025.
• Over 3 years, Accumulated Expenses stood at $1.2 million in 2024, then tumbled by 81.48% to $224038.0 in 2025, then increased by 6.47% to $238538.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $238538.0, $224038.0, and $73333.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.